Navigation Links
TorreyPines Therapeutics to Present at Susquehanna Financial Group's Second Annual SIGnificant Options in Healthcare Conference
Date:2/26/2008

LA JOLLA, Calif., Feb. 26 /PRNewswire/ -- TorreyPines Therapeutics, Inc. (Nasdaq: TPTX) today announced that Dr. Neil Kurtz, President and Chief Executive Officer of TorreyPines, will present at Susquehanna Financial Group's Second Annual SIGnificant Options in Healthcare Conference in New York City on Tuesday, March 4th at 11:00 a.m., Eastern.

A webcast of Dr. Kurtz's presentation will be available live. You can access the webcast at: http://www.torreypinestherapeutics.com. An archived version of the remarks will also be available through the Company's web site for a limited time following the conference.

About TorreyPines Therapeutics

TorreyPines Therapeutics, Inc. is a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of small molecules. The company is developing versatile product candidates, each potentially capable of treating a number of different diseases and disorders, including chronic pain, muscle spasticity and rigidity, cognitive disorders and xerostomia, or dry mouth. Further information is available at http://www.torreypinestherapeutics.com.

Company Contact: Media Contact:

Craig Johnson David Schull

TorreyPines Therapeutics, Inc. Russo Partners, LLC

858-623-5665, x158 212-845-4271

cjohnson@torreypinestherapeutics.com david.schull@russopartnersllc.com

Investor Contact: I
'/>"/>

SOURCE TorreyPines Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. TorreyPines Therapeutics Reports Third Quarter 2007 Results
2. TorreyPines Therapeutics to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
3. TorreyPines Therapeutics to Present at ThinkEquitys ThinkClinic Conference
4. TorreyPines Therapeutics and Eisai Co., Ltd. Extend Genetics Discovery Collaboration for Alzheimers Disease
5. TorreyPines Therapeutics to Present at ThinkEquitys G5 Conference
6. TorreyPines Therapeutics to Present at the NewsMakers in the Biotech Industry Conference
7. Hsiao Dee Lieu, M.D., F.A.C.C. Named VP of Clinical Research of Nile Therapeutics
8. The Diabetes Series 2008: Experts Speak About Developing Diabetes Therapeutics
9. CV Therapeutics Announces Presentations at the American College of Cardiology 57th Annual Scientific Session
10. Sirion Therapeutics Acquires Worldwide License to Develop New Treatment for Ocular Diseases
11. Ocera Therapeutics Closes $35.5 Million Series C Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... FL (PRWEB) May 16, 2013 As the ... to showcase their favorite Spring looks. While most make a ... season. Unfortunately, many women find the warmer weather mixes makeup ... women cope with the onset of acne during warmer months, ... from female acne treatment users the best ways to deter ...
(Date:5/16/2013)... , May 16, 2013 ... research report is available in its ... Competitor Analysis: Therapeutic Proteins – ... http://www.reportlinker.com/p01171947/Competitor-Analysis-Therapeutic-Proteins-–-Biosimilars-Biobetters--Biosuperiors.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharmaceutical   ... The new Competitive Intelligence ...
(Date:5/16/2013)... BioInformatics LLC New Market Report – ... Cells: Current and Future Opportunities (13-004) , With ... the primary cells market continues to increase. In this ... most often, how satisfied scientists are with commercially available ... growth rate. ,  , Additionally, terminally differentiated cells ...
(Date:5/16/2013)... 16, 2013 Dr. Stephen Y. Chou, ... titled “Nanoimprint Lithography and Applications” at IEEE Nano 2013 ... invented in 1995 by Chou, is becoming one of ... unique combination of sub-10 nm resolution, large area, and ... impacting both R&D and manufacturing in a broad range ...
Breaking Biology Technology:Adult Acne Treatment, Probiotic Action Shares New Tips for Women on How to Fight Acne While Wearing Makeup 2Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 2Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 3Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 4Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 5Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 6Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 7Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 8BioInformatics LLC New Market Report – The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities (13-004) 2BioInformatics LLC New Market Report – The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities (13-004) 3Founder, Prof. Stephen Chou to Give Tutorial on Nanoimprint at IEEE Nano 2013 2
... Mass., Sept. 30 NxStage Medical,Inc. (Nasdaq: NXTM ... that Jeffrey H. Burbank, Chief Executive Officer,and Robert S. ... JMP,Securities Healthcare Focus Conference on October 6, 2008 at ... presentation is scheduled for Monday, October 6th at,2:30 p.m. ...
... active U.S. Security ... ... today a new partnership that benefits those,career candidates with an active ... sites. The partnership includes,cross-promotion and delivery of online job postings, advertising, ...
... Inc. (OTC,Bulletin Board: BTEL) announced results for the year ... $0.23 per diluted share, on revenues of,$11,495,000. This compares ... revenues of $11,233,000 for the prior year. For its ... $0.07 per diluted share, on,revenues of $3,187,000. This compares ...
Cached Biology Technology:NxStage Medical to Present at JMP Securities Healthcare Focus Conference 2onTargetjobs and ClearedConnections Announce Online Recruitment Partnership 2Biotel Announces Record Revenues and Earnings for Fiscal 2008 2
(Date:5/16/2013)... MARC (Maximizing Access to Research Careers) Program has ... Society (ENDO) 95th Annual Meeting in San Francisco, ... meant to promote the entry of students, postdoctorates ... of the basic science community and to encourage ... 2013 Annual Meeting. , Awards are given to ...
(Date:5/16/2013)... Northwestern University scientists have shown a gene involved in ... proper function of the circadian clock. , In ... found the gene, called Ataxin-2, keeps the clock responsible ... the gene, the rhythm of the fruit fly,s sleep-wake ... schedule difficult for the fly. , The discovery ...
(Date:5/16/2013)... do so many sports players and athletes choose to ... study to be published in Psychological Science , ... that it may have to do with their testosterone ... Daniel Farrelly of the University of Sunderland and colleagues, ... in a competitive task had higher testosterone levels than ...
Breaking Biology News(10 mins):Gene involved in neurodegeneration keeps clock running 2High-testosterone competitors more likely to choose red 2
... University researcher has created a compound that prevents replication of ... treatment for the disease. "The outbreak of SARS in ... and there is currently no treatment," said Arun Ghosh, the ... is not currently a threat, there is the concern that ...
... CHAPEL HILL Many children love sending and receiving text ... annoyance of their parents. But now a new study ... this technology could be used to reduce children,s chances of ... monitor and modify their own behaviors now. Recent ...
... using optical probes means that changes in cells in ... completely different light. Prof David Parker from Durham ... University, and a team of international researchers, when they ... emitted by optical probes during a series of experiments. ...
Cached Biology News:Purdue researcher invents molecule that stops SARS 2Purdue researcher invents molecule that stops SARS 3UNC study: Text messaging may help children fight off obesity 2UNC study: Text messaging may help children fight off obesity 3Luminescence shines new light on proteins 2
Bovine Serum Available Anticoagulants: N-02: Citrate N-04: Heparin (Na) N-06: K2EDTA N-08: Potassium Oxalate N-10: EDTA (Na) N-03: Alsevers N-05: ACD N-07: CPD N-09: K3EDTA N-11:...
Anti-Mouse Qa.m8, Ascites (Clone 5035-24.1) (mouse IgG3)...
... TriEx Sf9 Cells and TriEx Insect Cell ... pTriEx baculovirus constructs. This cell/medium combination has ... growth and high protein expression levels observed ... vectors. Please note that our Ready-Plaque Sf9 ...
...
Biology Products: